Kewaunee Scientific Co. (NASDAQ:KEQU) Director Keith M. Gehl Purchases 403 Shares

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) Director Keith M. Gehl purchased 403 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were acquired at an average cost of $49.00 per share, for a total transaction of $19,747.00. Following the purchase, the director now owns 17,000 shares of the company's stock, valued at $833,000. This represents a 2.43 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Kewaunee Scientific Trading Down 6.0 %

Shares of KEQU traded down $2.99 during midday trading on Friday, hitting $46.50. The stock had a trading volume of 9,536 shares, compared to its average volume of 22,354. Kewaunee Scientific Co. has a 1 year low of $30.82 and a 1 year high of $71.33. The firm has a market cap of $132.76 million, a PE ratio of 7.37 and a beta of 0.71. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The stock's 50 day moving average is $57.46 and its 200 day moving average is $47.75.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The business had revenue of $67.17 million for the quarter.

Remove Ads

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research note on Friday, March 14th.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE grew its holdings in shares of Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after purchasing an additional 443 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock worth $30,000 after purchasing an additional 900 shares during the last quarter. IFP Advisors Inc bought a new position in shares of Kewaunee Scientific in the fourth quarter worth about $36,000. Morgan Dempsey Capital Management LLC bought a new position in shares of Kewaunee Scientific in the fourth quarter worth about $106,000. Finally, Barclays PLC bought a new position in shares of Kewaunee Scientific in the third quarter worth about $121,000. 32.69% of the stock is currently owned by institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.